Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700330200 on May 1, 2007

J. Biol. Chem., Vol. 282, Issue 25, 18584-18596, June 22, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/25/18584    most recent
M700330200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reineke, E. L.
Right arrow Articles by Kao, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reineke, E. L.
Right arrow Articles by Kao, H.-Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Aberrant Association of Promyelocytic Leukemia Protein-Retinoic Acid Receptor-{alpha} with Coactivators Contributes to Its Ability to Regulate Gene Expression*Formula

Erin L. Reineke{ddagger}1, Heng Liu{ddagger}, Minh Lam§, Yu Liu{ddagger}, and Hung-Ying Kao{ddagger}2

From the {ddagger}Department of Biochemistry, School of Medicine, Case Western Reserve University, and the §Research Institute of University Hospitals of Cleveland and the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 44106

The aberrant association of promyelocytic leukemia protein-retinoic acid receptor-{alpha} (PML-RAR{alpha}) with corepressor complexes is generally thought to contribute to the ability of PML-RAR{alpha} to regulate transcription. We report here that PML-RAR{alpha} acquires aberrant association with coactivators. We show that endogenous PML-RAR{alpha} interacts with the histone acetyltransferases CBP, p300, and SRC-1 in a hormoneindependent manner, an association not seen for RAR{alpha}. This hormone-independent coactivator binding activity requires an intact ligand-binding domain and the NR box of the coactivators. Confocal microscopy studies demonstrate that exogenous PML-RAR{alpha} sequesters and colocalizes with coactivators. These observations correlate with the ability of PML-RAR{alpha} to attenuate the transcription activation of the Notch signaling downstream effector, CBF1, and of the glucocorticoid receptor. This includes attenuation of the glucocorticoid-induced leucine zipper (GILZ) and FLJ25390 target genes of the endogenous glucocorticoid receptor. Furthermore, treatment of NB4 cells with all-trans-retinoic acid, which promotes PML-RAR{alpha} degradation, resulted in increased activation of GILZ. On the basis of these findings, we propose a model in which the hormone-independent association between PML-RAR{alpha} and coactivators contributes to its ability to regulate gene expression.


Received for publication, January 12, 2007 , and in revised form, May 1, 2007.

* This work was supported in part by National Institutes of Health Grant P30 CA43703-12 from the Confocal Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

1 Supported by Case Comprehensive Cancer Center Research Oncology Training Grant T32 CA059366-11 from NCI, National Institutes of Health.

2 Recipient of American Cancer Society Grant RSG-04-052-01-GMC. To whom correspondence should be addressed: Dept. of Biochemistry, School of Medicine, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-368-1150; Fax: 216-368-3419; E-mail: hxk43{at}cwru.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
E. L. Reineke, M. Lam, Q. Liu, Y. Liu, K. J. Stanya, K.-S. Chang, A. R. Means, and H.-Y. Kao
Degradation of the Tumor Suppressor PML by Pin1 Contributes to the Cancer Phenotype of Breast Cancer MDA-MB-231 Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 997 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Qiu, Y. Huang, G. Chen, Z. Chen, D. J. Tweardy, and S. Dong
Aberrant Chromatin Remodeling by Retinoic Acid Receptor {alpha} Fusion Proteins Assessed at the Single-Cell Level
Mol. Biol. Cell, October 1, 2007; 18(10): 3941 - 3951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement